Literature DB >> 21710158

Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation.

Cecilia A Larocca1, John W McEvoy, Carla L Ellis, Jacqueline Junkins-Hopkins, Todd Kolb, Alan N Baer, Brian T Garibaldi.   

Abstract

Schnitzler's syndrome (SS) is a rare inflammatory disease of unknown origin characterized by chronic urticaria and monoclonal gammopathy (usually IgM) associated with at least two of the following components: fever, arthralgia or arthritis, bone pain, hepato- and/or splenomegaly, lymphadenopathy, elevated erythrocyte sedimentation rate, leukocytosis, and/or abnormal findings on bone morphological investigations. To date, about 100 cases have been described with only 4 being reported in the USA. The mean time to diagnosis from the onset of disease is 5.4 years, given the varied symptoms with which patients may present. The pathogenesis of SS remains unknown but likely involves dysregulation of the IL-1 pathway. We describe here a 48-year-old woman with a monoclonal IgM gammopathy and a 3-year history of chronic pruritic urticarial dermatosis, unexplained fevers, chronic polyarthritis, lymphadenopathy, leukocytosis, hepatomegaly, and weight loss. She also had a history of chronic pancreatitis as well as a family history of recurrent pancreatitis. The diagnosis of Schnitzler's syndrome was made, and she was successfully treated with the IL-1 receptor antagonist, anakinra.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710158     DOI: 10.1007/s10067-011-1804-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Schnitzler's syndrome: successful treatment of two patients using thalidomide.

Authors:  M Worm; G Kolde
Journal:  Br J Dermatol       Date:  2003-03       Impact factor: 9.302

Review 2.  IL-1 pathways in inflammation and human diseases.

Authors:  Cem Gabay; Céline Lamacchia; Gaby Palmer
Journal:  Nat Rev Rheumatol       Date:  2010-02-23       Impact factor: 20.543

3.  Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab.

Authors:  K M Ramadan; H A Eswedi; M R El-Agnaf
Journal:  Br J Dermatol       Date:  2007-03-13       Impact factor: 9.302

4.  Interleukin-1beta and the autoinflammatory diseases.

Authors:  Charles A Dinarello
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

5.  Schnitzler's syndrome presenting as fever of unknown origin (FUO). The role of cytokines in its systemic features.

Authors:  E M de Kleijn; D Telgt; R Laan
Journal:  Neth J Med       Date:  1997-10       Impact factor: 1.422

6.  Schnitzler's syndrome associated with sensorimotor neuropathy.

Authors:  C Lebbe; M Rybojad; F Klein; E Oksenhendler; M Catala; F Danon; P Morel
Journal:  J Am Acad Dermatol       Date:  1994-02       Impact factor: 11.527

7.  Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy.

Authors:  Hiroyuki Murota; Yukiko Shoda; Tomohiko Ishibashi; Hiroyuki Sugahara; Itaru Matsumura; Ichiro Katayama
Journal:  J Am Acad Dermatol       Date:  2009-07-25       Impact factor: 11.527

8.  Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia: a variant of Schnitzler's syndrome?

Authors:  D Nashan; C Sunderkötter; G Bonsmann; T Luger; S Goerdt
Journal:  Br J Dermatol       Date:  1995-07       Impact factor: 9.302

9.  Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.

Authors:  J Norman; M Franz; J Messina; A Riker; P J Fabri; A S Rosemurgy; W R Gower
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

10.  Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition--higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia).

Authors:  J H Saurat; J Schifferli; G Steiger; J M Dayer; L Didierjean
Journal:  J Allergy Clin Immunol       Date:  1991-08       Impact factor: 10.793

View more
  4 in total

Review 1.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

Review 2.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130

Review 3.  Schnitzler's syndrome: lessons from 281 cases.

Authors:  Heleen D de Koning
Journal:  Clin Transl Allergy       Date:  2014-12-05       Impact factor: 5.871

4.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.